ChemPartner, a leader in Peptide Synthesis and Development, will be at the Boulder Peptide Symposium, Sept. 24-27, 2018 in Boulder, Colorado. The program was organized by Dr. Yvonne Angell, who is the Head of Peptide Operations at ChemPartner. There are 43 speakers, including a Showcase of emerging Peptide Companies, a CEO roundtable, a Peptide Analytics Workshop, and plenty of opportunities to network and learn about recent advancements in peptide research and therapeutics. ChemPartner will be presenting on Chemerin Analogs Selective for CMKLR1 and KISS1R Peptide Agonists for Prostate Cancer.
More information about the conference: https://boulderpeptide.org
